A detailed history of Aqr Capital Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 589,313 shares of ADMA stock, worth $10.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
589,313
Previous 773,406 23.8%
Holding current value
$10.4 Million
Previous $8.65 Million 36.25%
% of portfolio
0.02%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.21 - $20.03 $2.06 Million - $3.69 Million
-184,093 Reduced 23.8%
589,313 $11.8 Million
Q2 2024

Aug 14, 2024

SELL
$5.98 - $11.18 $260,411 - $486,855
-43,547 Reduced 5.33%
773,406 $8.65 Million
Q1 2024

May 15, 2024

BUY
$4.4 - $6.74 $993,300 - $1.52 Million
225,750 Added 38.18%
816,953 $5.39 Million
Q4 2023

Feb 14, 2024

BUY
$3.08 - $4.52 $151,412 - $222,203
49,160 Added 9.07%
591,203 $2.67 Million
Q3 2023

Nov 14, 2023

BUY
$3.47 - $4.61 $313,118 - $415,987
90,236 Added 19.97%
542,043 $1.94 Million
Q2 2023

Aug 14, 2023

BUY
$3.12 - $4.22 $974,978 - $1.32 Million
312,493 Added 224.31%
451,807 $1.67 Million
Q1 2023

May 15, 2023

BUY
$3.01 - $3.87 $49,553 - $63,711
16,463 Added 13.4%
139,314 $461,000
Q4 2022

Feb 14, 2023

BUY
$2.47 - $3.88 $120,177 - $188,781
48,655 Added 65.58%
122,851 $476,000
Q3 2022

Nov 14, 2022

BUY
$2.03 - $2.86 $150,617 - $212,200
74,196 New
74,196 $180,000
Q3 2020

Nov 16, 2020

SELL
$2.04 - $3.74 $59,598 - $109,264
-29,215 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$2.42 - $3.29 $70,700 - $96,117
29,215 New
29,215 $86,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.48B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.